Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 12/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EPHB3 | P54753 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29779352 | 1.00 | NTRK1 (0.45) | NTRK1LMNAATMNR3C1SMN1; SMN2 | |
| SCHEMBL15809947 | 0.88 | LMNA (0.53) | NTRK1LMNANR3C1POLB | |
| SCHEMBL304006 | 0.86 | ATM (0.47) | ATMSMN1; SMN2 | |
| SCHEMBL122740 | 0.85 | LMNA (0.56) | NTRK1LMNAATMNR3C1SMN1; SMN2 | |
| SCHEMBL29369397 | 0.85 | LMNA (0.56) | NTRK1LMNAATMNR3C1SMN1; SMN2 | |
| SCHEMBL232104 | 0.85 | NTRK1 (0.56) | NTRK1LMNAATM | |
| SCHEMBL29419096 | 0.85 | NTRK1 (0.56) | NTRK1LMNAATM | |
| SCHEMBL27716556 | 0.84 | ATM (0.46) | LMNAATMDHODH | |
| SCHEMBL303173 | 0.84 | POLB (0.46) | LMNAATMNR3C1SMN1; SMN2EPHB3 | |
| SCHEMBL4449376 | 0.84 | NTRK1 (0.50) | NTRK1LMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | claimed |
| CN-106614611-B | Fungicidal compositions | 先正达参股股份有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-106614612-B | Fungicidal compositions | 先正达参股股份有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-106614620-B | Fungicidal compositions | 先正达参股股份有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-106614610-B | Fungicidal compositions | 先正达参股股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| US-7799334-B2 | Pyrazolecarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | CBR3, CBR1, CYC1 | NTRK1 3863/4885LMNA 1444/4885ATM 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.